SO-38 Clinical efficacy and single-cell analysis of combined BRAF, MEK, and PD-1 inhibition in BRAFV600E colorectal cancer patients

Autor: Corcoran, R., Tian, J., Chen, J., Chao, S., Pelka, K., Baiev, I., Sindurakar, P., Allen, J., Meyerhardt, J., Enzinger, A., Enzinger, P., McCleary, N., Klempner, S., Yurgelun, M., Abrams, T., Clark, J., Ryan, D., Giannakis, M., Parikh, A., Hacohen, N.
Zdroj: In Annals of Oncology June 2022 33 Supplement 4:S373-S373
Databáze: ScienceDirect